Holen Sie sich die Stockscreener-App
88.57
0.65%
-0.58
Handel nachbörslich:
88.57
Schlusskurs vom Vortag:
$89.15
Offen:
$89.19
24-Stunden-Volumen:
2.27M
Relative Volume:
1.08
Marktkapitalisierung:
$17.33B
Einnahmen:
$8.23B
Nettoeinkommen (Verlust:
$705.10M
KGV:
24.97
EPS:
3.5467
Netto-Cashflow:
$1.12B
1W Leistung:
+0.80%
1M Leistung:
-10.03%
6M Leistung:
-9.84%
1J Leistung:
-21.03%
1-Tages-Spanne:
$87.62
$89.19
1-Wochen-Bereich:
$85.83
$89.61
52-Wochen-Spanne:
$84.59
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
88.57 | 17.33B | 8.23B | 705.10M | 1.12B | 3.5467 |
ABT
Abbott Laboratories
|
103.99 | 180.70B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.44 | 125.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.17 | 102.80B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.34 | 45.74B | 6.07B | 1.06B | 1.34B | 1.8063 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-23 | Herabstufung | BTIG Research | Buy → Neutral |
| 2026-02-20 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2026-01-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Hochstufung | Roth Capital | Neutral → Buy |
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
A4D66C Bond Analysis — Key Metrics - TradingView
A4D66C Latest News and Headlines - TradingView
How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Split On Growth And Execution - Yahoo Finance
Title Zimmer Biomet Stability (NYSE:ZBH) How S&P 500 Trends Shape Confidence - Kalkine Media
Vanguard disaggregates holdings; Zimmer Biomet (ZBH) shows 0 shares - Stock Titan
Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH) For Its Upcoming Dividend? - simplywall.st
Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026 - PR Newswire
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Stock Faces Pressure from Analyst Downgrades and Modest 2026 Guidance Amid Knee Growth - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (ZBH) Latest Stock News & Headlines - Yahoo Finance
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now? - sharewise.com
Operating profit of Zimmer Biomet Holdings, Inc. from 2021 to 2025 - Statista
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
BTIG downgrades Zimmer Biomet Holdings (ZBH) - MSN
Zimmer Biomet: Down On Its Knees, Shares Look Appealing (NYSE:ZBH) - Seeking Alpha
BTIG downgrades Zimmer Biomet, sees limited upside amid growth challenges - Investing.com Canada
This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Zimmer Biomet (NYSE:ZBH) Given Neutral Rating at BTIG Research - MarketBeat
BTIG Downgrades Zimmer Biomet Holdings(ZBH.US) to Hold Rating - Moomoo
BTIG Downgrades Zimmer Biomet Holdings (ZBH) Rating to Neutral | ZBH Stock News - GuruFocus
Zimmer Biomet stock rating cut to neutral by BTIG on growth concerns - Investing.com
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by Northside Capital Management LLC - MarketBeat
Gains Recap: Will Zimmer Biomet Holdings Inc benefit from AI trends2026 Stock Rankings & Precise Swing Trade Alerts - baoquankhu1.vn
Wilsey Asset Management Inc. Invests $32.44 Million in Zimmer Biomet Holdings, Inc. $ZBH - marketbeat.com
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Surgical Equipment & ConsumablesDiversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers - Yahoo Finance
Pre-market 19 Mar 2026: ZBH.SW Zimmer Biomet (SIX) CHF67.50 -4.26%: analyst grade - Meyka
Canaccord Genuity Maintains Zimmer Biomet Holdings (ZBH) Hold Recommendation - MSN
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ZIMMER BIOMET HOLDINGS INCRo Khanna Congressional Trade on Feb. 05, 2026 - Quiver Quantitative
JPMorgan Chase & Co. Reduces Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Stock (ISIN: US98956P1021) Faces Institutional Selling Pressure Amid Steady D - AD HOC NEWS
Moore Capital Management LP Trims Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Delta Global Management LP Makes New Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Ameriprise Financial Inc. Has $373.24 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Knee Replacement Market Set to Witness Significant Growth from - openPR.com
ZBH.SW down 4.26% pre-market on SIX: Zimmer Biomet faces near-term support test - Meyka
Zimmer Biomet declares $0.24 dividend - MSN
How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance
Winkler Lori, SVP of Zimmer Biomet, sells $250k in stock - Investing.com Australia
Winkler Lori, SVP of Zimmer Biomet, sells $250k in stock By Investing.com - Investing.com South Africa
Zimmer Biomet Holdings Insider Sold Shares Worth $250,849, According to a Recent SEC Filing - marketscreener.com
Zimmer Biomet (NYSE:ZBH) SVP Sells $250,849.00 in Stock - MarketBeat
Zimmer Biomet (NYSE: ZBH) SVP sells 2,650 shares in open market - Stock Titan
Cash per share of Zimmer Biomet Holdings, Inc. – VIE:ZBH - TradingView
Is Zimmer Biomet’s Q4 Beat And 2026 Guidance Altering The Investment Case For ZBH? - simplywall.st
Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN
Zimmer Biomet (ZBH) Valuation Check After Earnings Beat And Updated Growth Outlook - Yahoo Finance
Zimmer Biomet (ZBH) Valuation Check As AAOS 2026 Robotics And Smart Implant Showcase Nears - Sahm
Dodge & Cox Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):